[HTML][HTML] MERS coronavirus: diagnostics, epidemiology and transmission
IM Mackay, KE Arden - Virology journal, 2015 - Springer
The first known cases of Middle East respiratory syndrome (MERS), associated with infection
by a novel coronavirus (CoV), occurred in 2012 in Jordan but were reported retrospectively …
by a novel coronavirus (CoV), occurred in 2012 in Jordan but were reported retrospectively …
[HTML][HTML] MERS-CoV: understanding the latest human coronavirus threat
A Chafekar, BC Fielding - Viruses, 2018 - mdpi.com
Human coronaviruses cause both upper and lower respiratory tract infections in humans. In
2012, a sixth human coronavirus (hCoV) was isolated from a patient presenting with severe …
2012, a sixth human coronavirus (hCoV) was isolated from a patient presenting with severe …
Rationally engineered Cas9 nucleases with improved specificity
The RNA-guided endonuclease Cas9 is a versatile genome-editing tool with a broad range
of applications from therapeutics to functional annotation of genes. Cas9 creates double …
of applications from therapeutics to functional annotation of genes. Cas9 creates double …
Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia
Outbreaks of Middle East respiratory syndrome (MERS) raise questions about the
prevalence and evolution of the MERS coronavirus (CoV) in its animal reservoir. Our …
prevalence and evolution of the MERS coronavirus (CoV) in its animal reservoir. Our …
[HTML][HTML] MERS-CoV spillover at the camel-human interface
Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus from camels
causing significant mortality and morbidity in humans in the Arabian Peninsula. The …
causing significant mortality and morbidity in humans in the Arabian Peninsula. The …
[HTML][HTML] Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections
Background: Highly effective novel treatments need to be developed to suppress emerging
coronavirus (CoV) infections such as COVID-19. The RNA dependent RNA polymerase …
coronavirus (CoV) infections such as COVID-19. The RNA dependent RNA polymerase …
[HTML][HTML] Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea
Abstract Middle East Respiratory Syndrome coronavirus (MERS-CoV) was first isolated from
a patient with severe pneumonia in 2012. The 2015 Korea outbreak of MERSCoV involved …
a patient with severe pneumonia in 2012. The 2015 Korea outbreak of MERSCoV involved …
MERS-CoV as an emerging respiratory illness: a review of prevention methods
S Baharoon, ZA Memish - Travel medicine and infectious disease, 2019 - Elsevier
Abstract Introduction Middle East Respiratory Coronavirus Virus (MERS-CoV) first emerged
from Saudi Arabia in 2012 and has since been recognized as a significant human …
from Saudi Arabia in 2012 and has since been recognized as a significant human …
[HTML][HTML] Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19
M Ko, SY Chang, SY Byun, A Ianevski, I Choi… - Viruses, 2021 - mdpi.com
Therapeutic options for coronaviruses remain limited. To address this unmet medical need,
we screened 5406 compounds, including United States Food and Drug Administration …
we screened 5406 compounds, including United States Food and Drug Administration …
[HTML][HTML] Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle …
Middle East respiratory syndrome coronavirus (MERS-CoV) causes an acute and severe
lower respiratory illness as well as vomiting, diarrhea, and renal failure. Because no …
lower respiratory illness as well as vomiting, diarrhea, and renal failure. Because no …